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PE 144.398/fin./Part A 
OR.FR 
By 1 etter of 11 June 1990 the Counci 1 consulted the European Parliament, 
pursuant to Article 130q (2) of the EEC Treaty on the Commission proposal for 
a Council decision adopting a specific research and technological development 
programme in the field of biomedicine and health (1990-1994). 
At the sitting of 15 June 1990 the President of Parliament announced that he 
had referred this proposal to the Committee on Energy, Research and Technology 
as the committee responsible and to the Committee on Budgets and the Committee 
on the Environment, Public Health and Consumer Protection for their opinions. 
At its meeting of 22 May 1990 the Committee on Energy, Research and Technology 
appointed Mr Pompidou rapporteur. 
At its meetings of 28 June, 16 October, 7 November and 28 November 1990 it 
considered the Commission proposal and the draft report. 
At the last meeting it adopted the draft legislative resolution by 14 votes, 
with 4 abstentions. 
The following took part in the vote: Adam, chairman; Salzer, vice-chairman; 
Pompidou, rapporteur; Anger, Bettini, Breyer, Ernst de la Graete (for 
Lannoye), Garcia Arias, Gasoliba 1 Bohm, Lar1ve, Linkohr, Pierros, 
Quisthoudt-Rowohl, Regge, Robles Piquer, Rovsing, Sanz Fernandez and 
Verwaerde. 
The opinion of the Committee on Budgets and the Committee on the Environment, 
Public Health and Consumer Protection are attached. 
The report was tabled on 22 November 1990. 
The deadline for tabling amendments wi 11 appear on the draft agenda for the 
part-session at which the report is to be considered. 
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A 
Commission proposal for a Council decision adopting a specific research and 
technological development programme in the field of biomedicine and health 
(1990-1994) 
1 
Commission text1 Amendments 
(Amendment No. 1) 
After the third recital, new recital a 
Whereas fundamental research must be 
specifically encouraged Community-
wide in each of the strategic 
research sectors of the Framework 
Programme; 
(Amendment No. 2) 
After the third recital, new recital b 
Whereas, in addition to the specific 
programme on human capital and 
mobility, training of researchers in 
each of the strategic research 
sectors of the Framework Programme 
must be ensured; 
(Amendment No. 3) 
After the third recital, new recital c 
Whereas the social, human and 
environmental impact of the 
programme must be assessed by an 
independent panel and technology and 
risk assessment be undertaken, 
particularly in the field of 
bioethics; 
For full text see COM(90) 0162 final -OJ No. C 174, 16.7.1990, p. 65 
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Commission text Amendments 
(Amendment No. 4) 
Fourth recital 
Whereas, pursuant to Article 4 and 
Annex I of Decision 90/221/EURATOM, 
EEC, the amount deemed necessary for 
the whole framework programme 
includes an amount of 57 million ECU 
for the centralized dissemination 
and exploitation of results, to be 
divided up in proportion to the 
amount envisaged for each activity; 
whereas in view of the importance of 
this specific programme within the 
life sciences and technologies 
action the estimate of the financial 
resources needed by this programme 
is to be reduced by 1.33 million 
ECU, which amount is to be allocated 
to the centralized activities, in 
order to comply with the second 
sentence of Article 130p(2) of the 
Treaty; 
Whereas, pursuant to Art i c 1 e 4 and 
Annex I of Decision 90/221/EURATOM, 
EEC, the amount deemed necessary for 
the whol '! framework programme 
includes an amount deemed necessary 
of 57 million ECU for the 
centralized dissemination and 
exploitation of results which is to 
be the subject of a decision of the 
Council in cooperation with 
Parliament; whereas, in view of the 
importance of this specific 
programme within the life sciences 
and technologies action a financial 
contribution to the centralized 
activities is required; whereas this 
contribution is proportional to th~ 
fi nanc i a 1 _s_~_p~c.it_y_of t~___prog_ram111~ 
~-1)-~ --~(!rresponds _ t9 _ the eff~_ct i ye 
g_!!manc1_...f9_r:____l_h._P, .I~~J:!~!J:s __ !,lf __ r:~search_ 
from the socio-economic operators in 
all the Member States; 
(Amendment No. 5) 
Sixth recital 
whereas this programme must be 
implemented essentially by the 
selection of research and 
development projects to enable them 
to benefit from Community 
participation; whereas the 
Commission should encourage the 
submission of such projects by the 
usual means of publishing calls for 
proposals in the Official Journal of 
the European Communities; whereas a 
!.Q~£l.!iJ_ procedure should also be 
devised so as to maintain a degree 
of flexibility enabling the 
Commission, in the face of the 
continuous evolution and gradual 
acceleration of technological 
progress, also to take into 
cons ide ration spontaneous propos a 1 s 
consistent with the objectives of 
the programme; 
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whereas this programme must be 
implemented essentially by the 
selection of research and 
development projects to enable them 
to benefit from Community 
participation; whereas the 
Commission should encourage the 
submission of such projects by the 
usual means of publishing calls for 
proposals in the Official Journal of 
the European Communities; whereas ~~ 
ex~I!P!JJ>_~_a 1 procedure shou I d a I so be 
devised so as to come into effect 
between calls for proposals to 
maintain a degree of flexibility 
enabling the Commission, in the face 
of the continuous evolution and 
gradual acceleration of 
technological progress, also to take 
into cons ide ration spontaneous 
proposals consistent with the 
objectives of the programme; 
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Commission Amendments 
(Amendment No. 6} 
Article 1 
A specific research and 
techno 1 og i ca I deve 1 opment programme 
for the E~ropean Economic Community 
in the field of biomedicine and 
health, as -icfined in Annex I, is 
hereby ado~ted for ~ period of five 
years as from 1 January 1990. 
A specific research and 
technol ogi ca 1 deve 1 opment programme 
for the European Economic Community 
in the field of biomedicine and 
he a 1 th, as defined in Annex I, is 
hereby adopted for the period from 
the date of publication of this 
decision in the Official Journal to 
31 December 1994. 
Amendment No. 7 
Article 2(1) 
1. The Community funds estimated as 
necessary for the execution of the 
programme under this Decision amount 
to 133 mi 11 ion ECU. Of this amount 
1. 33 mi 11 ion ECU is drawn for the 
centralized dissemination and 
exploitation of results. The amount 
thus reduced to 131.67 million ECU 
includes staff costs which may not 
exceed 4%. An indicative breakdown 
of expend 1 ture is set out 1 n 
Annex II. 
1. The Community funds estimated as 
necessary for the execution of the 
programme under this Decision amount 
to 133 million ECU, including staff 
costs and a contribution to the 
centralized dissemination and 
exploitation of results. An 
indicative breakdown of expenditure 
for the implementation of this 
programme is set out i.~A!:!~_El~ __ Il~ 
The procedures for th~ 
dissemination and exploitation of 
results are set out in Annex I I I. 
An indicative breakdown of 
expenditure and the procedures 
concerning staff are set out in 
Annex II. 
{Amendment No. 8) 
Article 5{3) 
3. The reports sha 11 be drawn up 3. The reports sha 11 be drawn up 
having regard to the objectives set having regard to the objectives set 
out in Annex I to this Decision and out in Annex I to this Decision and 
in accordance with Article 2{4) of in accordance with Article 2{4) of 
Decision 90/221/Euratom, EEC. Decision 90/221/Euratom, EEC. These 
reports shall assess the coherence 
of the programme's measurable 
implementation with the six major 
concerns set out in Annex II of 
Council Decision 90/221/Euratom, 
EEC1 • 
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Commission text Amendments 
(Amendment No. 9) 
Article 6 
1. The Commission shall be 
responsible for the execution of the 
programme. It shall be assisted by 
a committee, hereinafter referred to 
as 'the Committee', composed of 
representatives of the Member States 
and chaired by a representative of 
the Commission. 
2. The contracts concluded by the 
Commission shall govern the rights 
and obligations of each party, 
including the procedures for 
disseminating, protecting and 
exploiting the research results, in 
accordance with the arrangements 
adopted pursuant to the second 
paragraph of Article 130k of the 
Treaty. 
3. A work programme for each year 
shall be drawn up and updated where 
necessary. It shall set out the 
detailed objectives and types of 
projects to be undertaken, and the 
financial arrangements to be made 
for them. The Commission shall make 
calls for proposals for projects on 
the basis of the annua 1 work 
programmes. 
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1. The Commission shall be 
responsible for the execution of the 
programme. It shall be assisted by 
a committee, hereinafter referred to 
as 'the Committee', composed of 
representatives of the Member States 
and chaired by a representative of 
the Commission. 
The European Parliament shall be 
informed of the deliberations of the 
committee in a comprehensive and 
timely manner. 
2. The contracts concluded by the 
Commission shall govern the rights 
and obligations of each party, 
inc 1 udi ng the procedures for 
disseminating, protecting and 
exploiting the research results, in 
accordance with the arrangements 
adopted pursuant to the second 
paragraph of Article 130k of the 
Treaty and, where appropriate, 
procedures for training and 
evaluation. 
3. A work programme sha 11 be drawn 
up at the start of the programme and 
shall be regularly revised. It 
shall set out the detailed 
objectives and types of projects to 
be undertaken, and the financial 
arrangements to be made for them. 
The Commission shall make calls for 
proposals for projects on the basis 
of the annual work programmes. 
PE 144.398/fin./Parl A 
OR.FR 
Commission Amendments 
(Amendment No. 10) 
Article 7 
1. In the ;ases envisaged in 
Article 8(1), the Commission 
represent,.. 1 ve shall submit to the 
Committee a draft of the measures to 
be taken. The Committee shall 
deliver its opinion on the draft 
within a time limit which the 
chairman may set according to the 
urgency of the matter. The opinion 
shall be delivered by the majority 
provided for in Article 148(2) of 
the Treaty for the adoption of 
decisions which the Council is 
called upon to make on a proposal 
from the Commission. When voting 
takes place in the Committee, the 
votes of the representatives of the 
Member States shall be weighted as 
specified in the above-mentioned 
article. The chairman shall not 
take part in the voting. 
2. The Commission shall adopt the 
measures envisaged where they are in 
accordance with the Committee's 
opinion. 
3. If the measures envisaged are not 
in accordance with the Committee's 
opinion, or if no opinion is 
delivered, the Commission shall 
forthwith submit to the Council a 
proposal relating to the measures to 
be taken. The Council shall act by 
a qualified majority. 
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1. In the cases envisaged in 
Article 8(1), the Commission 
representative shall submit to the 
Committee a draft of the measures to 
be taken. The Committee shall 
deliver its opinion on the draft 
within a time limit which the 
chairman may set according to the 
urgency of the matter if necessary 
by taking a vote. 
(Rest deleted.) 
2. The opinion shall be recorded in 
the minutes; in addition, each 
Member State shall have the right to 
ask to have its position recorded in 
the minutes. 
3. The Commission shall take the 
utmost account of the opinion 
delivered by the Committee. It 
shall inform the Committee of the 
manner in which its opinion has been 
taken into account. 
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Commission text Amendments 
(Amendment No. 11) 
Article 8 
1. The procedure 1 aid down in 
Article 7 shall apply to: 
the preparation and updating of 
the work programmes referred to 
in Article 6(3), 
evaluation of the projects 
referred to in point 2 of 
Annex III, as well as the 
estimated amount of the 
Community's financial 
contribution when these projects 
are submitted through the 
ordinary procedure referred to 
in point 4 of Annex III and the 
above-mentioned amount is more 
than 5 m ECU; 
evaluation of all projects 
submitted through the 
exceptional procedure referred 
to in point 4 of Annex I II, as 
well as the estimated amount of 
the Community's financial 
contribution, 
measures for evaluating the 
programme. 
2. The Commission may consult the 
Commit tee on any matter fa 11 i ng 
within the scope of the programme. 
3. The Commission shall inform the 
Committee with regard to: 
the progress of the programme, 
planned calls for proposals, 
referred to in Article 6(3), 
projects, referred to in point 2 
of Annex III, submitted through 
the ordinary procedure, for 
which the Community contribution 
is less than 5 m ECU, and the 
results of their evaluation, 
accompanying measures, referred 
to in point 2 of Annex Ill, 
concerted actions, referred to 
in point 2 of Annex III. 
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1 . The procedure 1 aid down in 
Article 7 shall apply to: 
the preparation and updating of 
the work programmes referred to 
in Article 6(3), 
the contents of calls for 
proposals, referred to in 
Annex II I, 
the participation in any project 
by non-Community organizations 
and enterprises referred to in 
Article 10, 
any adaptation of the indicative 
breakdown of funds set out in 
Annex II, 
the measures to be undertaken to 
evaluate the programme and those 
projects submitted through the 
exceptional procedure, 
accompanying measures and 
arrangements for the 
dissemination, protection and 
exploitation of the results of 
the research, for encouraging_ 
fundamental research, training of 
researchers and technological 
assessment carried out under the 
programme. 
The Commission shall notify the 
European Parliament of draft 
decisions which, in the exercise of 
the Commission's implementing 
powers, are forwarded to the 
Committee. 
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Commission text Amendments 
(Amendment No. 12) 
Article 10 
Where cooperation with third 
countrie. and international 
organizations a'm1ng at achieving 
the objectiv(>s of this programme 
requires leJal undertakings between 
the Community and the third parties 
concerned, the Commission sha 11 be 
authorized to negotiate, in 
accordance with Article 130n of the 
Treaty, international 
1 ayi ng down the terms 
cooperation. 
agreements 
of such 
Decisions on the conclusion of such 
agreements shall be adopted in 
accordance with the procedure 
referred to in Article 130q(2) of 
the Treaty. 
Where cooperation with third 
countries and international 
organizations aiming at achieving 
the objectives of this programme 
requires legal undertakings between 
the Community and the third parties 
concerned, the Commission sha 11 be 
authorized to negotiate, in 
accordance with Article 130n of the 
Treaty, international 
1 ayi ng down the terms 
cooperation. 
agreements 
of such 
Priority wi 11 a 1 so be given to 
cooperation with regional groupings 
and European countries not members 
of the European Community in 
accordance with the guidelines 
agreed between the Counc i 1 and the 
European Parliament1 . 
The negotiations for such 
international agreements may only be 
initiated with third countries who 
are already signatories of an 
agreement with the Community which 
explicitly cites research and 
technological development as one of 
the objectives of cooperation. 
Decisions on the conclusion of such 
international agreements shall be 
adopted in accordance with the 
procedure referred to in 
Article 130q(2) of the Treaty. 
1 Drawn up during the conciliation 
on the Framework Programme for 
Community activities in research and 
technological development 1990-1994. 
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Commission text Amendments 
(Amendment No. 13) 
Annex I, third paragraph 
Close coordination will be 
rna 1 nta 1 ned with other relevant 
research programmes, including 'Life 
sciences and technologies for 
developing countries', 'telematics 
systems - health care' and 'Medical 
research' under the European Coal 
and Steel Community Treaty. 
Close coordination will be 
rna i nta 1 ned with other relevant 
research programmes, i ncl ud i ng 
'Biotechnology', 'Life sciences and 
technologies for developing 
countries', 'telematics systems-
hea 1 th care' , 'Medica 1 research' 
under the European Coal and Steel 
Community Treaty and also the 
'Europe against Cancer' programme. 
(Amendment No. 14) 
Annex I, fourth paragraph 
The principle of subsidiarity will 
be applied to the maximum, through 
encouraging the harmonization of 
approaches and methodologies used in 
different national programmes. The 
projects themselves will have a 
European dimension arising from 
their polycentric execution based on 
research networks. 
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The principle of subsidiarity will 
be applied to the maximum. 
Harmonization of approaches and 
methodologies used in different 
national programmes will be 
- 11 -
encouraged. The projects within the 
programme wi 11 have a European 
dimension based on research 
networks. 
The existing research networks must 
be made more flexible to allow real 
interaction between laboratories and 
research centres and not just the 
exchange of information. Greater 
mobility of research workers should 
be encouraged, for example by_ 
facilitating short periods of work 
in the various 1 aboratori es. The 
research networks should also be 
strengthened by their developing 
specific very productive subject 
areas, in particular by developing 
open 1 aboratori es repre~ent Lr:'1.9 
s__~"l_tr:_~_s_ -~-f exce 11 enc_e _ _fQr _ _!>_~ ~-i ~- and 
~pplieQ_research. 
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OR.FR 
Commission text 
Harmonized methods, specified in the 
relevant protocols, will ensure that 
the data resulting from the projects 
carried out throughout the Community 
can be $tatistically analysed and 
coherently exr;oited anywhere in the 
Community. 
Amendments 
Harmonized methods, specific to the 
relevant protocols, will ensure that 
the data resulting from the projects 
carried out throughout the Community 
can be analysed and exploited 
anywhere in the Community. 
Coordination with national 
activities will ensure effective use 
of resources. 
(Amendment No. 15) 
Annex I, fifth paragraph 
Prenormat i ve research wi 11 be 
developed whenever needed for 
serving patients' needs and for the 
completion of the Internal Market. 
The fundamental role of basic 
research in underpinning the work of 
the programme is recognized. 
Prenormat i ve research wi 11 be 
developed whenever needed for the 
completion of the Internal Market in 
respect of serving patients' needs. 
(Amendment No. 16) 
Annex I, Area 1 
Area 1 . Harmonization of 
methodologies and protocols in 
epidemiological, biological and 
clinical research 
The essential features of this area 
are outlined below: Testing of drugs 
wi 11 be conducted through the 
development of networks, enabling 
both the collection of clinical and 
epidemiological data and the 
monitoring and surveillance of 
prescriptions and of adverse drug 
reactions. 
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Area 1. Development of coordinated 
research on prevention, care and 
health systems 
This area covers the harmonization 
of methodologies and protocols in 
epidemiological, biological, 
clinical and technological research. 
The key targets will be: 
Pre-competitive drug testing and 
research into the monitoring and 
survei 11 ance of drug prescribing 
practices, patient compliance and 
the 1 nc idence of adverse drug 
reactions will be carried out, based 
on clinical and epidemiological data 
co 11 ected through co-ordinated 
networks, and with a view to an 
improved harmonization of norms, 
parameters and 'guidelines'. 
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Commission text 
Screening for risk factors wi 11 be 
covered, especially in the context 
of occupational health. Examples of 
risk factors at work include 
shiftwork, new technology in the 
office and occupational health risks 
in health care workers. Safety in 
laboratories is of particular 
importance. Related topics include 
audit in occupational health and 
ethical problems. 
In biomedical technology, research 
will be directed towards the 
development of new coherent 
diagnostic procedures, such as 
medical imaging techniques. In the 
biomedical engineering area, the aim 
is to restore function as completely 
as possible to the handicapped, 
particularly by developing new 
biomaterials for use in prostheses, 
tissue replacements and artificial 
organs. Methods of monitoring the 
effects of treatment, and consequent 
restoration of function, wi 11 a 1 so 
be developed. 
Amendments 
Risk factors relating t~_ 
occupational health will be studied, 
with the aim of eliminating 
workplace hazards. Examples of risk 
factors at work include dangerous 
substances and biological agents, 
shiftwork, new technology in the 
office, and occupational health 
risks in health care workers. 
Related topics include audit in 
occupational health and effective 
means of informing workers about 
workplace safety issues. Research 
related to the genetic screening of 
workers for apparent predispositions 
to occupational diseases and 
workplace hazards will not be 
conducted. 
Enhancement and application of 
biomedical technology to medical and 
health care will be directed towards 
the development of coherent systems 
and procedures for diagnosis, 
therapy, prevention, care and 
rehabilitation. Co-ordination of 
basic research (modelling) in 
biomedical technology will be aimed 
at fundamental insight into failing 
human functions and on the 
characteristics of biomaterials. 
Applied technological research will 
be aimed at artificial systems to 
restore failing human functions and 
alleviate handicaps as completely as 
possible. 
Lastly, support must be given in 
these different fields to multi-
centre studies between countries to 
facilitate the granting of patents, 
epidemiological studies and 
authorizations for the marketing of 
new medicinal products. 
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Commission text 
Harmonization of protocols and 
approaches as regards the management 
of health services wi 11 be 
emphasized. 
Amendments 
Harmonization of protocols and 
approaches in health services wi 11 
be emphasized, ~articularly with 
Euro~e 1992 in view. Research wi 11 
be carried out into the financiD~_of 
.l:le!llh_._car~..t.-!-!'le_'!J.!na~!!"~~t __ of. t~e 
healtl:l care workforce, and h~J~h 
care systems. The methodology of 
research into ~revention, therapy 
and rehabilitation will also be 
studied. 
(Amendment No. 17) 
Annex I, Area 2, title and introduction 
Area 2. A~~lications to diseases of 
great socio-economic impact 
Five economically and socially 
significant disease groupings will 
be considered, as described below: 
Area 2. 
diseases 
impact 
Major health ~roblems and 
of great socio-economic 
Major health problems and 
economically and socially 
significant disease groupings will 
be considered, in particular the 
following: 
(Amendment No. 18) 
Annex I, Area 2, 'AIDS' 
AIDS 
The research will take into account 
the activities already developed by 
the Community and will be spread 
over five sectors: 
The disease prevention sector wi 11 
concentrate on specific 
epidemiological projects, studies of 
primary and secondary prevention, 
assessment of preventive strategies, 
behavioural research and 
forecasting, using inter ali a 
centres or facilities with unique 
characteristics. 
The fundamental research sector will 
concentrate on AIDS viruses, host 
response, pathogenesis and animal 
studies. 
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AIDS 
The research will take into account 
the activities already developed by 
the Community and will be spread 
over five main sectors: 
- disease prevention - concentrating 
on specific epidemiological 
projects, studies of primary and 
secondary prevention, assessment of 
preventive strategies, behavioural 
research and forecasting. 
-fundamental research-
concentrating on AIDS Vi ruses, 
host response, pathogenesis and 
experimental models. 
PE 144.398/fin./Part A 
OR.FR 
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Commission text 
The clinical research sector will 
concentrate on clinical trials, 
clinical manifestations, support of 
clinical centres and support of 
national coordination, e.g. by 
establishing a network of Clinical 
AIDS Reference Centres and other 
relevant groups. This immediately 
sensitive part of the programme will 
be given a special priority. 
Prenormat i ve research wi 11 be 
included, with development of new 
drugs being emphasized. 
The development of a European 
Vaccine against AIDS (EVA) wi 11 be 
act 1 vel y pursued. .B.~- _Q_bJ.ectjye_i!. 
the pro mot 1 on of _colJ!bor_at 1 ve 
research by the provision of high-
quality reagents for investigations 
of the immune response to 
lentiviruses and the induction of 
protective immunity. A centralized 
1 aboratory fac11 ity wi 11 be 
provided, and arrangements will be 
made for industrial and academic 
laboratories to produce to agreed 
specifications required amounts of 
anti gens, sera, ce 11 s and other 
materials; the centralized facility 
will be responsible for assaying the 
materials, together with their 
adequate storage and distribution. 
Amendments 
- clinical research - concentrating 
on clinical trials, clinical 
manifestations, support of 
clinical centres and national co-
ordination, 
- the development of a European 
Vaccine against AIDS (EVA) will 
be actively pursued. A 
centralised facility will work in 
collaboration with industrial and 
academic 
antigens, 
materials, 
- testing 
Drugs in 
wi 11 be 
laboratories 
sera, cells 
to produce 
and other 
methods of Antiviral 
AIDS Management (ADAM} 
developed. Primary 
screening 
increased 
additional 
capacity wi 11 be 
by introducing 
primary screening 
methods. 
In this speci.f_i~ __ area coll !bor~_t_i_on 
w1_th _ _Q_t_b_e_r_ ___ E~:~_r:pp_e_a_~ ____ Cq_r_n_l!lun.1.ty 
!.<:J i_on_s.J --~_n __ p_~r~ 1_~u_l_~r _ l!l.~ s~e-~_ifi~. 
p_t:...~!"~lll~ .. of._ ___ _!'_e s e_~!'.<:l!. _ ~n_Q 
technological development in the 
field of Life Sciences and 
technologies for developing 
countries will receive particular 
attention. 
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Commis:>ion text 
Testing meth')ds for Anti vi ra 1 Drugs 
in AIDS Management {ADAM), the most 
recent dom:.. in of research, wi 11 be 
devel opr> J. Primary screening 
capacity w1l~ be increased by 
introducing additional primary 
screening 11ethods; further research 
wi 11 be undertaken on the mode of 
action of promising compounds, and 
consideration may be given to ways 
of scaling up their production. 
Amendments 
{Amendment No. 19} 
Annex I, Area 2, 'Cancer' 
Cancer 
Research will concentrate on 
improved methodologies involving 
differing combinations of surgery, 
radiotherapy, chemotherapy and 
immunotherapy, and their subsequent 
harmonization. Local approaches 
involving surgery and radiotherapy 
will be studies vis-a-vis improved 
methods of removing all visible 
tumour tissue, aiming to leave a 
minimal tumour burden with resulting 
maximization of the effects of new 
systemic treatments as they become 
available. More effective methods 
of local control, as well as of 
systemic treatments, will be 
developed in order to achieve rapid 
improvement in overa 11 survi va 1 . 
Selectivity of radiotherapy will be 
further improved, e.g. using light 
ion therapy and Boron neutron 
capture therapy (BNCT), aiming at an 
improved survival rate. 
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Cancer 
Epidemiology and fundamental 
research on genomic and phenotypic 
changes in cancer cells {invasion 
and metastasis) and immune 
surveillance will be extended. 
Particular attention will b~___Qai_Q__!_Q_ 
research into oncogenes and anti-
oncogenes. Priority support 
activities will include the 
improvement of European tumour cell 
and tissue bank resources, and the 
development of the scientific basis 
for common guidelines for anti-
cancer drug screening. 
Research will concentrate on 
improved methodologies involving 
differing combinations of surgery, 
radiotherapy, chemotherapy and 
immunotherapy, and their subsequent 
harmonization with associated local 
and general approaches. 
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OR.FR 
Commission text 
Epidemiology and fundamental 
research on genomic and phenotypic 
changes in cancer cells (invasion 
and metastasis) and immune 
surveillance will be extended. 
Priority support activities will 
include the improvement of European 
tumour cell and tissue bank 
resources, and the development of 
the scientific basis for common 
guidelines for antt-cancer drug 
s c '::'.!~_t!!g . 
Amendments 
Research wi 11 a 1 so be carried out 
regarding the environmental 
relationships which lead to 
increased incidence of cancer with 
the aim of developing approaches. 
In conjunction with the 'Europe 
against Cancer' programme, a 
specific sector of the programme 
will be directed at research in the 
area of pediatrjc oncol9~Y· 
(Amendment No. 20) 
Annex I, Area 2, 'Cardiovascular disease' 
Cardiovascular disease 
The various forms of heart and 
circulatory disease will be studied, 
focusing on research where coherent 
broadly-based clinical surveys are 
most useful; this includes 
correlation between lifestyle, 
nutrition and the incidence and 
development of cardiovascular 
disturbances, the effects of 
prophylactic and therapeutic 
measures, the development of new 
regimens for the treatment and the 
testing of drugs. 
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Cardiovascular disease 
The various forms of heart and 
circulatory disease will be studied, 
focus 1 ng on research where coherent 
broadly-based clinical ~~­
epidemiological surveys are most 
useful; this will include 
correlation between genetic factors, 
lifestyle, nutrition and the 
incidence and development of 
cardiovascular disturbances, the 
effects of prophylactic and 
therapeutic measures, the 
development of new regimens for 
treatment including non-invasive 
methods of diagnosis, and the 
testing of drugs. 
PE 144.398/fin./Part A 
OR.FR 
Commission text Amendments 
(Amendment No. 21) 
Annex I, Area 2 
'Mental illness and neurological disorders, and mental handicap' 
Mental illnes<: and neurological 
disorders, and mental handicap 
A comparative analysis of 
aetiopathogenetic factors and 
conditions relative to the incidence 
of mental illness in widely 
different psycho-social environments 
will be carried out in order to 
obtain an insight into the 
responsible mechanisms. Systems for 
the handling and treatment of 
patients wi 11 be compared in order 
to identify the most effective. A 
coherent, multidisciplinary approach 
to __ !~e study of central nervous 
!.Y.~tem rnal_func~J~nin!] common !_q 
me!I..!_~L __ 111 ness and neu_ro I..Q.91£.!]_ 
disorders will be pursued. Multiple 
sclerosis and Parkinson's disease 
are examples. 
A comparative study of the handling 
of the menta 11 y handicapped and of 
their rehabilitation will be carried 
out. The approach will be broad and 
comprehensive, ranging from the 
mo 1 ecul ar to the socio-economic 
aspects. 
Mental illness 
disease 
and neurological 
Multi disciplinary approaches to the 
study of aetiological factors and 
predisposing conditions will be 
developed in a range of psycho-
social environments. The aim of 
such studies will be to improve 
understanding of the causes of 
mental illness and also the 
evolution from pathology to 
disability and social disadvantage, 
and to develop new methods of 
prevention and care. 
A gl oba 1 approach to the study of 
central nervous system 
malfunctioning common to pathologic 
and physiopathologic conditions will 
be pursued, to improve understanding 
of aetiopathogenic mechanisms. 
(Amendment No. 22) 
Annex I, Area 2 
'Ageing and age-related health problems and disabilities' 
Ageing and age-reI a ted 
problems and d1sab1litie~ 
health 
Comparative research on perinatal 
and paediatric illnesses and on the 
effectiveness of prophylactic and 
therapeutic measures will be carried 
out. 
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Ageing, age-reI a Led he a 1 th problems 
and handicaps 
Research on perinatal ( i ncl udi ng the 
study of the social and economic 
impact of prenatal diagnosis) and 
paediatric illnesses and on the 
effectiveness of prophylactic and 
therapeutic measures will be carried 
out. 
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A concerted approach to the study of 
ageing, with emphasis on the 
clinical aspects, will be pursued in 
order to identify, on a large-scale 
factual basis, essential elements in 
the rna i ntenance of the qua 1 i ty of 
1 i fe in the aged, in preventing or 
delaying the functional decline of 
the individual, and in reducing 
costs to society. Special attention 
will be given to the effects of the 
environment on health, especially on 
people in the more vulnerable ages; 
this will be pursued in close 
liaison with research on 
environmental protection. 
. ~· Amendments 
The over a 11 target for research in 
the field of ageing will be directed 
towards prevention of and coping 
with dependency. A concerted 
approach to the study of aging will 
be pursued in order to identify 
essential elements in the 
rna i ntenance of the qua 1 ity of 1 i fe 
in the aged, in preventing or 
delaying the functional decline of 
the individual, and in reducing 
costs to society. Emphasis wi 11 be 
placed on longitudinal studies on 
ageing in different cultural 
settings, and on specific 
pathologies related to ageing such 
as senile dementia, osteoporosis, 
and disorders of the immune system. 
Special attention will be given to 
the effects of the environment on 
health, especially on people in the 
more vulnerable age groups; this 
will be pursued in close liaison 
with research on environmental 
protection. 
Organ transplants 
Studies will be carried out on 
methods of improving organ 
transplants. 
(Amendment No. 23) 
Annex I , Area 3 
Area 3. Human genome analysis 
This research will be developed 
towards the comp 1 et ion and the 
integration of the genetic and 
physical maps. In addition, the 
study of the genetic basis for 
biological functions will be 
pursued, as well as the setting-up 
of a consort i urn to sequence a 
portion of the genome of major 
biological interest (e.g. the 
portion coding for the human 
lymphocyte antigen system). 
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Area 3. Human genome analysis 
This research wi 11 be developed 
towards the completion and the 
integration of the genetic and 
physical maps. In addition, the 
study of the genetic basis for 
biological functions wi 11 be 
pursued, as we 11 as the setting-up 
of a coordinating mechanism to 
sequence a portion of the genome of 
major biological interest (e.g. the 
portion coding for the human 
lymphocyte antigen system). 
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Emphasis wi 11 be p 1 aced on medica 1 
applications which contribute to the 
well-being of patients: in 
particular, on understanding the 
genetic component of multi factori a 1 
cond it i r ns such as Alzheimer's 
disease, and Jn developing methods 
intended '!:o improve therapies. 
Links ~F.il be maintained with 
appropriate international 
organizations or forums {e.g. HUGO, 
the Human Genome Organization), as 
well as with research actions in 
non-member states using similar or 
comp 1 ementary approaches. The 
Community programme is characterized 
by its emphasis on gene mapping and 
on the use of information resulting 
from the analysis of other species' 
genomes. 
Particular attention and caution 
will be given to the ethical, social 
and legal aspects of this work, 
especially to those which may be 
linked to possible misuses of 
research findings. No research 
modifying, or seeking to modify, the 
genetic constitution of human beings 
by a 1 terat ion of germ ce 11 s or of 
any stage of embryo development 
which may make these alterations 
hereditary will be carried out under 
this programme. 
Amendments 
Emphasis will be placed on medical 
applications which contribute to the 
well-being of patients, ~ 
coordination with other elements of 
BIOMED 1, to ensure that the 
advances in the understanding of 
genetics are used to enhance human 
health: in particular, on 
understanding the genetic component 
of multifactorial conditions such as 
Alzheimer's disease, and on 
developing methods intended to 
improve therapies. 
Links will be maintained with 
appropriate international 
organizations or forums {e.g. HUGO, 
the Human Genome Organization}, as 
well as with research actions in 
non-member states using similar or 
complementary approaches. The 
Community programme is characterized 
by its emphasis on gene mapping and 
on the use of information resulting 
from the analysis of other species' 
genomes. It is therefore important 
that BIOMED 1 should link closely 
with relevant activities elsewhere 
in the Framework Programme. 
Particular attention will be given 
to the ethical, social and legal 
aspects of this work, especially to 
those which may be linked to 
possible misuses of research 
findings. No research modifying, or 
seeking to modify, the genetic 
constitution of human beings by 
alteration of germ cells or of any 
stage of embryo development which 
may make these alterations 
hereditary will be carried out under 
this programme. 
However, the results of this 
research must enable the genetic 
data of the donors required for 
transplants to be established at any 
time. 
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(Amendment No. 24) 
Annex I, Area 4 (new} 
Amendments 
Area 4: Research on bioethical 
aspects 
Studies will deal with: 
-the compilation of current 
legislation on bioethics and 
current projects; 
- the organization of meetings of 
experts in the field of bioethics 
with a view to drawing up 
Community positions; 
- the assessment of the bioethical 
aspects of the various research 
programmes in the framework 
programme of Community activities 
and research. 
Preparatory studies will be 
undertaken with a view to the 
setting up of a European ethical 
observatory in conjunction with the 
European institutions and 
organizations. 
(Amendment No. 25) 
Annex II 
INDICATIVE BREAKDOWN OF EXPENDITURES INDICATIVE BREAKDOWN OF EXPENDITURES 
for the period 1990-1994 
Area 1: 
Harmonization of methodologies and 
protoc:ol s 1n eptde~ndologlcal, 
b1olog1cal and clinical research 
20-25% 
Area 2: 
for the period 1990-1994 
Area 1: 
Harmonization of methndoloqie~ and 
protocols 
b1olog1cal 
20-25% 
Area 2: 
In .,ptdornlolo<Jical, 
and cl ln1cal re5earch 
Applications to diseases 
socio-economic impact 
45-50% 
of great Applications to diseases of great 
socio-economic impact 
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55-60% 
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Area 3: 
Human genome analysis 
30-35% 
The breakdown between different 
areas does not exclude the 
possibility that projects could 
cover several areas. 
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Amendments 
Area 3: 
Human genome analysis 
20-25% 
Area 4 
Research on bioethical aspects: 
5% of the total for Areas 1, 2 and 3 
The breakdown between different 
areas does not exclude the 
possibility that projects could 
cover several areas. 
The establishment plan deemed 
necessary for the duration of the 
programme consists of 18 statutory 
posts (A, B and/or C). The 
Commission shall indicate each year 
in the preliminary draft budget the 
number of staff deemed necessary and 
the corresponding expenditure. 
The budgetary authority shall decide 
on appropriations. 
This amendment represents the 
transfer of 15 m ECU from Area 3: 
human genome ana 1 ys is, to Area 2: 
applications to diseases of great 
socio-economic impact. This 
transfer has no budgetary effect for 
human genome analysis as this field 
already has funding of 15 m ECU for 
1991-1992. 
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1. An amount equivalent to 10% of 
the total shall be used for projects 
encouraging fundamental research 
which should be clearly identified. 
2. An amount equ iva 1 ent to 5% of 
the tot a 1 sha 11 be devoted to 
projects encouraging the training of 
researchers in the fields covered by 
this specific programme. 
PE 144.398/fin./Part A 
OR.FR 
Commission text Amendments 
3. The projects mentioned in 
paragraphs 1 and 2 shall be the 
subject of agreements concluded with 
the universities and research 
institutes organized in research 
networks. 
4. The results of the technological 
and risk assessment for bioethical 
aspects, as provided for in Area 4 
above, shall be communicated to 
Parliament with the evaluation 
reports. 
(Amendment No. 26) 
Annex III, Paragraph 2, fourth subparagraph 
The concerted actions are those 
defined in the Financial Regulation. 
The concerted actions 
defined in Article 92 
Financial Regulation. 
are those 
of the 
Rates of Community participation 
will be in accordance with Annex IV 
of Council Decision 90/221/Euratom, 
EEC. 
(Amendment No. 27) 
Annex III, Paragraph 3 
3. The participants in the projects 
must be natural or legal persons 
established in the Community, such 
as universities, research 
organizations and industrial firms, 
including small and medium-sized 
enterprises, or associations 
thereof, in particular European 
Economic Interest Groupings 
(EEIGs). 
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3. The participants in the projects 
must be natural or legal persons 
established in the Community, such 
as universities, research 
organizations and industrial firms, 
including small and medium-sized 
enterprises, or associations 
thereof, in particular European 
Economic Interest Groupings 
(EEIGs). 
II1~_J?3!!.: L'l.fJ..P.!l.~_is. __ _i n_ !-b_e ___ p _r_<>_j_~~_l_s_ 
must make 50% of their research and 
deve 1 opment expenditure in the 
European Community. 
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Natural or legal persons established 
in countries which have concluded 
co-operation agreements on 
scientific and technical research 
with 1 the Community, may, on the 
principle of mutual benefit, 
p a r t i' c i p a t e i n t h e p r o j e c t s 
undertaken in the framework of this 
programme. Such contracting 
part 1 e s will not benefit from 
Community financing. They will 
contribute to the general 
administrative costs. 
Amendments 
The Commission reserves the right to 
check a posteriori whether the 
applicant has made at least 50% of 
research and development expenditure 
in the Community. If this were not 
the case, the Commission would be 
entitled to cancel funding of the 
programme. 
Natural or legal persons established 
in countries which have concluded 
co-operation agreemenls on 
scienllfic and lechnical research 
with the Community, may, on the 
principle of mutual benefit, 
participate in the projects 
undertaken in the framework of this 
programme. Such contracting 
parties will not benefit from 
Community financing under the 
Framework Programme. They wi 11 
contribute to the general 
administrative costs. 
(Amendment No. 28) 
Annex III, Paragraph 4 
4. The choice of projects shall be 
carried out according to the 
following order of priority, the 
first method being the rule, the 
second the exception. 
The participants in the projects 
sha 11 be selected on the basis of 
the ordinary procedure of calls for 
proposals referred to in Article 
6(3) and published in the Official 
Journal of the European Communities. 
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4. The choice of projects shall be 
carried out according to the 
following order of priority, the 
first method being the rule, the 
second the exception. 
The participants in the projects 
shall be selected on the basis of 
the ordinary procedure of calls for 
proposals referred to in Article 
6(_!_) and published in the Official 
Journal of the European Communities. 
Where other criteria of scientific 
excellence are satisfied, and in 
accordance with the guidelines 
agreed between Council and the 
European Parliament, in the case of 
a number of project proposals of 
equal scientific value, preference 
shall be given: 
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The Commission may a 1 so accept 
proposals according to an 
exceptional procedure and under the 
conditions mentioned below, when 
they make a particularly promising 
and significant contribution as 
regards the originality of the theme 
proposed, the nove 1 ty of the 
scientific and technical approach 
and the methodology of execution, 
also taking into account the 
particular nature of the proposers. 
A favourable technical evaluation of 
such propos a 1 s sha 11 not by i tse 1 f 
be a sufficient justification for 
accepting a project; this 
exceptional procedure may only apply 
after verification that the nature 
of the project, as defined above, 
does not justify the use of the 
normal procedure for calls for 
proposals. 
Amnndrncnt!> 
(i) to project proposals whose 
implementation involves project 
participants in less-developed 
regions and/or regions in industrial 
decline as defined by Articles 8 and 
9 of Council Regulation EEC No. 
2052/88. 
(ii) to project proposals involving 
small and medium-sized enterprises 
or an association of such 
enterprises. 
The Commission shall determine in 
each case whether the management of 
the programme, or parts there~~!~ 
be undertaken by organizations or 
institutions outside the Commission, 
and it shall delegate the work 
accordingly. 
The Commission may a 1 so accept 
proposals according to an 
exception a 1 procedure and under the 
conditions mentioned below, when 
they make a part i cul arl y promising 
and significant contribution as 
regards the originality of the theme 
proposed, the nove 1 ty of the 
scientific and technical approach 
and the methodology of execution, 
also taking into account the 
particular nature of the proposers. 
A favourable technical evaluation of 
such proposals shall not by itself 
be a sufficient justification for 
accepting a project; this 
exceptional procedure may only apply 
after veri fi cation that the nature 
of the project, as defined above, 
does not justify the use of the 
norma 1 procedure for ca 11 s for 
proposals. 
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The exceptional procedure must be 
completed before the ordinary 
procedure in such a way that the 
available amount for the Community's 
financial participation in projects 
retained by the ordinary procedure 
can be de+ ermined precise 1 y. The 
closing date for the exceptional 
procedure shall be published each 
year in the Official Journal of the 
European Communities. 
The amount of the fi nanc i a 1 
participation of the Community for 
all the projects retained by the 
exception a 1 procedure wi 11 be 
decided each year, in relation to 
the project selected according to 
particularly strict criteria of 
excellence. In any case this amount 
may not exceed 15%; it may be 
revised each year in the 1 i ght of 
experience. 
The Commission shall draw up a vade 
mecum setting out all the rules 
applicable to this exceptional 
procedure in order to guarantee full 
transparency. 
Amendments 
The exceptional procedure shall come 
into effect after the first call for 
proposals and must be completed 
before the ordinary procedure in 
such a way that the available amount 
f o r t h e Co mm u n i t y ' s f i n an ci a 1 
participation in projects retained 
by the ordinary procedure can be 
determined precise 1 y. The closing 
date for the exception a 1 procedure 
shall be published each year in the 
Official Journal of the European 
Communities. 
When it submits the preliminary 
draft budget the Commission shall 
inform the budgetary authority 
whether the appropriations approved 
in the budget of the previous year 
have also financed projects retained 
by the excepti9nal procedure and the 
amounts allocated. Should these 
projects cover several programmes, 
it shall state the type of committee 
which assisted it 
The amount of the fi nanc i a 1 
participation of the Community for 
all the projects retained by the 
exception a 1 procedure wi 11 be 
decided each year, in relation to 
the project selected according to 
particularly strict criteria of 
excellence. In any case this amount 
may not exceed 10% of the annual 
budget appropriations; it may be 
revised each year in the 1 i ght of 
experience. 
The Commission shall draw up a vade 
mecum setting out all the rules 
applicable to this exceptional 
procedure in order to guarantee full 
transparency. 
It sha 11 forwar<L!b.i ~ade __ mecu!!l _ _!._Q 
Parliament at the latest before this 
Decision is adopted. 
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(Amendment No. 29) 
Annex III, after paragraph 4, new paragraph 4a 
4a. No Member State may attribute 
to a national, regional, local, 
departmental or other governmental 
budget any Community funds allocated 
to organizations of that Member 
State in implementation of projects 
accepted under the terms of the 
project selection procedure 
described in paragraph 4 above. 
(Amendment No. 30) 
Annex III, paragraph 7 
7. The knowledge acquired during 
the course of the projects shall be 
disseminated on the one hand within 
the specific programme and on the 
other hand by means of a centralized 
activity, pursuant to the decision 
referred to in the third paragraph 
of Article 4 in Decision 
90/221/EURATOM, EEC. 
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7. The knowledge acquired during 
the course of the projects shall be 
disseminated with the specific 
programme and by means of, and in 
compliance with, the prov1s1ons 
governing the centralized action to 
be the subject of a decision taken 
by the Council in cooperation with 
Parliament pursuant to the third 
paragraph of Art i c 1 e 4 in Decision 
90/221/EURATOM, EEC. The financial 
contribution of this programme 
amounts to . . . . ECU, in accordance 
with the financial provisions of 
Council Decision concerning 
centralized activities. 
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A 
DRAFT LEGISLATIVE RESOLUTION 
(Cooperation procedure: first reading} 
embody~ng the opinion of the European Parliament on the Commission proposal 
for a Council decision adopting a specific programme 
of research and technological development in 
the field of biomedicine and health (1990-1994} 
The European Parliament, 
having regard to the Commission proposal to the Council {COM{90} 0162 final 
- SYN 267} 2 , 
having been consulted by the Council pursuant to Article 130q(2} of the EEC 
Treaty (C3-0165/90}, 
having regard to the report of the Committee on Energy, Research and 
Technology and the opinions of the Committee on Budgets and the Committee 
on the Environment, Public Health and Consumer Protection (A3-0328/90), 
having regard to the Commission position on the amendments adopted by 
Parliament, 
1. Approves the Commission proposal subject to Parliament's amendments and in 
accordance with the vote thereon; 
2. Cans on the Commission to amend its proposal accordingly, pursuant to 
Article 149(3) of the EEC Treaty; 
3. Calls for the conciliation procedure to be opened if the Council should 
intend to depart from the text approved by Parliament; 
4. Asks to be consulted again should the Council intend to make substantial 
modifications to the Commission proposal; 
5. Calls on the Council to incorporate Parliament's amendments in the common 
position that it adopts in accordance with Article 149(2)(a) of the EEC 
Treaty; 
6. Instructs its President to forward this opinion to the Council and 
Commission. 
2 OJ No. C 174, 16.7.1990, p. 65 
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